Brian Q. Le

Array ( [id] => 3646800 [patent_doc_number] => 05605689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Treatment of HIV-associated immune thrombocytopenic purpura' [patent_app_type] => 1 [patent_app_number] => 8/237962 [patent_app_country] => US [patent_app_date] => 1994-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6496 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605689.pdf [firstpage_image] =>[orig_patent_app_number] => 237962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831586 [patent_doc_number] => 05846534 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Antibodies to the antigen campath-1' [patent_app_type] => 1 [patent_app_number] => 8/235705 [patent_app_country] => US [patent_app_date] => 1994-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 9087 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846534.pdf [firstpage_image] =>[orig_patent_app_number] => 235705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3555455 [patent_doc_number] => 05519117 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-21 [patent_title] => 'Isolated, tyrosinase derived peptides and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/233305 [patent_app_country] => US [patent_app_date] => 1994-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 32 [patent_no_of_words] => 7289 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/519/05519117.pdf [firstpage_image] =>[orig_patent_app_number] => 233305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3704364 [patent_doc_number] => 05674984 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Method for isolation of unclipped HIV envelope protein' [patent_app_type] => 1 [patent_app_number] => 8/226162 [patent_app_country] => US [patent_app_date] => 1994-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 23821 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674984.pdf [firstpage_image] =>[orig_patent_app_number] => 226162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3411523 [patent_doc_number] => 05443957 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'Anti-asialo-GM1 monoclonal antibodies and method of use' [patent_app_type] => 1 [patent_app_number] => 8/225075 [patent_app_country] => US [patent_app_date] => 1994-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4403 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/443/05443957.pdf [firstpage_image] =>[orig_patent_app_number] => 225075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4307365 [patent_doc_number] => 06241986 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Human monoclonal antibodies to the CD4-binding domain of HIV, uses thereof and synergistic neutralization of HIV' [patent_app_type] => 1 [patent_app_number] => 8/215395 [patent_app_country] => US [patent_app_date] => 1994-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 11044 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/241/06241986.pdf [firstpage_image] =>[orig_patent_app_number] => 215395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3521267 [patent_doc_number] => 05530096 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-25 [patent_title] => 'Isolated, tyrosinase derived peptides and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/203054 [patent_app_country] => US [patent_app_date] => 1994-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 30 [patent_no_of_words] => 6905 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/530/05530096.pdf [firstpage_image] =>[orig_patent_app_number] => 203054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3666704 [patent_doc_number] => 05597896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-28 [patent_title] => 'Retrovirus human immunodeficiency virus type 2(HIV2), capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes' [patent_app_type] => 1 [patent_app_number] => 8/202260 [patent_app_country] => US [patent_app_date] => 1994-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5012 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/597/05597896.pdf [firstpage_image] =>[orig_patent_app_number] => 202260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590683 [patent_doc_number] => 05487890 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-30 [patent_title] => 'Mammalian primate erythrocyte bound heteropolymerized monoclonal antibodies and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/186136 [patent_app_country] => US [patent_app_date] => 1994-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4102 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/487/05487890.pdf [firstpage_image] =>[orig_patent_app_number] => 186136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3485779 [patent_doc_number] => 05470570 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'Mammalian primate erythrocyte bound heteropolymerized monoclonal antibodies and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/161812 [patent_app_country] => US [patent_app_date] => 1993-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4080 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470570.pdf [firstpage_image] =>[orig_patent_app_number] => 161812 [rel_patent_id] =>[rel_patent_doc_number] =>)